“In vivo, a lower dose of idazoxan was necessary to ameliorate hyperglycaemia induced by the α2-agonist … channel opener, indicating α2A-antagonism as the predominant mechanism of action (decrease in incremental area under the glucose curve induced …/kg idazoxan : under diazoxide, -3±7%, vs. …, -34±9%, P<0.02).”